Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Complement Polymorphism Plays Role in RA Pathology

  |  Issue: June 2015  |  

In this way, the investigators revealed that a single amino acid change in C5 results in a complement polymorphism that is associated with a subtle change in individual component function that translates into dramatic effects on complement activity and RA disease risk. (posted 4/13/15)

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference
1. Giles JL, Choy E, van den Berg C, et al. Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J Immunol. 2015. Feb 27. doi: 10.4049/jimmunol.1402956 [Epub ahead of print].

 

ADVERTISEMENT
SCROLL TO CONTINUE

Related Articles

    Researchers Seek ANCA-Associated Vasculitis Subtype Markers

    New research on complement activation in anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis underscores its important role in the patho­genesis of this disease, an autoimmune condition defined by inflammation of small- and medium-caliber blood vessels.1 ANCA testing is commonly performed to help diagnose granulomatosis with polyangiitis and microscopic polyangiitis, both of which are forms of ANCA-associated…

    Study: Can Avacopan Replace Steroids in ANCA-Associated Vasculitis?

    A phase 3 trial described in The New England Journal of Medicine (NEJM) highlights the potential of a C5a receptor inhibitor, avacopan, for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis.1 Avacopan may potentially offer a steroid-sparing option for the treatment of this serious disease. Current Treatment of ANCA-Associated Vasculitis Morbidity and mortality from ANCA-associated vasculitis have…

    Reading Rheum

    Handpicked Reviews of Contemporary Literature